Halofantrine-associated Ventricular Fibrillation in a Young Woman with no Predisposing QTc Prolongation
- 1 January 1997
- journal article
- case report
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 29 (2) , 207-208
- https://doi.org/10.3109/00365549709035889
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Cardiac Effects of Standard-Dose Halofantrine TherapyThe American Journal of Tropical Medicine and Hygiene, 1996
- Electrocardiographic Changes and Halofantrine Plasma Level During Acute Falciparum MalariaThe American Journal of Tropical Medicine and Hygiene, 1996
- Cardiac complications of halofantrine: a prospective study of 20 patientsTransactions of the Royal Society of Tropical Medicine and Hygiene, 1995
- Provocation of ventricular tachycardia by antimalarial drug halofantrine in congenital long QT syndromeClinical Cardiology, 1994
- Antimalarial prophylaxis Manufacturers recommend more stringent guidelines for halofantrineBMJ, 1994
- Cardiac effect of halofantrineThe Lancet, 1993
- Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malariaThe Lancet, 1993
- Cardiac effects of antimalarial treatment with halofantrineThe Lancet, 1993
- Measurement of halofantrine and its major metabolite desbutylhalofantrine in plasma and blood by high-performance liquid chromatography: a new methodologyJournal of Chromatography B: Biomedical Sciences and Applications, 1992
- Pharmacokinetics of halofantrine in man: effects of food and dose size.British Journal of Clinical Pharmacology, 1989